Open Access

Alterations in the glutathione metabolism could be implicated in the ischemia-induced small intestinal cell damage in horses

  • Gonzalo Marañón1,
  • William Manley1,
  • Patricia Cayado1,
  • Cruz García2,
  • Mercedes Sánchez de la Muela3 and
  • Elena Vara2Email author
BMC Veterinary Research20095:10

DOI: 10.1186/1746-6148-5-10

Received: 22 February 2008

Accepted: 18 March 2009

Published: 18 March 2009

Abstract

Background

Colic could be accompanied by changes in the morphology and physiology of organs and tissues, such as the intestine. This process might be, at least in part, due to the accumulation of oxidative damage induced by reactive oxygen (ROS) and reactive nitrogen species (RNS), secondary to intestinal ischemia. Glutathione (GSH), being the major intracellular thiol, provides protection against oxidative injury. The aim of this study was to investigate whether ischemia-induced intestinal injury could be related with alterations in GSH metabolism.

Results

Ischemia induced a significant increase in lipid hydroperoxides, nitric oxide and carbon monoxide, and a reduction in reduced glutathione, and adenosine triphosphate (ATP) content, as well as in methionine-adenosyl-transferase and methyl-transferase activities.

Conclusion

Our results suggest that ischemia induces harmful effects on equine small intestine, probably due to an increase in oxidative damage and proinflammatory molecules. This effect could be mediated, at least in part, by impairment in glutathione metabolism.

Background

Colic refers to any cause of abdominal pain and is the leading cause of death in horses. Much of the mortality is associated with ischemic-injured intestine because of the rapid deterioration of the intestinal barrier, absorption of bacterial lipopolysacharide and subsequent circulatory collapse [1]. Certain processes that can take place during equine colic, like intestinal ischemia and/or endotoxemia [14] can subject the intestine to an increased burden of oxidative stress [4, 5], with the subsequent accumulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS are highly reactive molecules which are mainly generated in mitochondria during oxygen metabolism. Impairment in mitochondrial function may reduce the energy supply to the cells. It has been suggested that the increase in oxidative stress could be, at least in part, responsible for this fact [6].

Two molecules that have been recently involved in oxidative damage and inflammatory response are Nitric oxide (NO) and Carbon monoxide (CO). Nitric oxide can act as both inflammatory mediator and RNS, either directly or through peroxynitrites generated by its interaction with O2- [7, 8]. CO is one of the elements of the heme-oxygenase 1 (HO-1)-CO pathway, which has been proposed to constitute a defence system against oxidative and inflammatory damage [9].

In the past, many studies have been shown that glutathione (GSH), a well-known antioxidant [10, 11] protects cells and organs from various forms of injury induced by hypoxia, ischemia, cold preservation and drugs [12, 13]. This has been used as evidence for a role of oxygen free radicals in such injury because the metabolism of GSH suppresses the cytotoxic effects of the reactive radicals [14, 15]. Nevertheless, GSH is also essential in preserving the ability of the cell to generate ATP and to maintain membrane integrity [13], and it has been suggested that GSH may protect cells by mechanisms independent of its antioxidant properties.

Oxidative stress secondary to free radical generation may play a role in the tissue damage associated with intestinal ischemia [5]. Mitochondria are major producers of ROS, i.e. O2- and H2O2. H2O2if not reduced to water, can lead to the formation of very reactive hydroxyl radicals resulting in the formation of lipid hydroperoxides (LPO) that can damage mitochondria membranes and functions reducing the energy supply to the cells. Since mitochondria do not contain catalase, GSH as a cofactor of the glutathione peroxidase is the only mitochondrial defence to coupe with H2O2 produced endogenously in aerobic cells. Thus, GSH is critical in protecting unsaturated fatty acids in membrane phospholipids from peroxidation by attack of oxygen free radicals. GSH depletion results in cell injury and death in several cell types and organs [15, 16] and it has been shown that glutathione is required for intestinal function [16], but, to our knowledge, no studies concerning the role of glutathione metabolism in horse intestine have been done.

On the other hand, S-Adenosyl methionine (SAMe) an endogenous metabolite synthesized in the cytosol of all types of cells from ATP and methionine [17], in a reaction catalyzed by the enzyme methionine-adenosyl-transferase (MAT), plays a critical role in the synthesis of glutathione [18, 19]. SAMe plays a critical role in the synthesis of glutathione (GSH) [18, 19]. Conversely, depletion of GSH could result in a decrease of MAT activity, which in turn can result in a further decrease of GSH levels thus increasing cell damage. SAMe also participates in polyamine synthesis and it acts as methyl donor for most biological transmethylation reactions, catalysed by methyl-transferases (MetTase), including the methylation of phosphatidyl ethanolamine to produce phosphatidyl choline (PC), which is an essential molecule for cell membrane integrity.

The aim of this study was to asses a possible association between alterations in the glutathione metabolism and intestinal ischemia-induced oxidative/antioxidative imbalance in horses. For this purpose GSH, LPO and ATP content, as well as NO and CO release was determined in intestinal tissue of horses. Additionally, MAT and Met Tase activities have also been investigated.

Methods

Patients

Twenty-nine adult horses with acute abdominal pain subjected to emergency abdominal surgery of the small intestine, referred to our clinic during the last year, were used. The ages ranged from 5 to 20 years with a mean of 11 years. On arrival, the same protocol for acute abdominal emergency reception was applied to each horse. A complete anamnesis was performed at time of presentation (duration of signs, previous medical treatment....), and a clinical evaluation to asses degree of pain, response to analgesia, abdominal distention, hydration status, rectal examination findings and amount of gastric reflux. Degree of abdominal pain was assessed by the attending clinicians as mild (occasional pawing, occasionally turning the head to the flank, stretching out), moderate (cramping with attempts to lie down, kicking at the abdomen, laying down and attempting to roll or rolling) or severe (sweating, dropping to the ground, violent rolling) [20].

At presentation, rectal temperature varied from 37.6 to 38.5°C (38.1 ± 0.7°C), heart rate ranged from 45 to 90 beats/min (68 ± 23 beats/min), and respiratory rate ranged from 10 to 30 breaths/min (20 ± 10 breaths/min). All of the 29 colic horses had moderate or severe pain. The response to analgesia was mild in 14 horses and poor in 15. Transrectal palpation of the abdominal organs was performed in all cases.

The cases were composed of one inguinal hernia, 5 lipomas, 2 intussusceptions (parasites), 1 horse with small intestinal adhesions and 20 intestinal volvulus. All horses received the same standard protocol of medication (flunixin-meglumine+xylazine).

Horses were premedicated with intravenous (IV) romifidine and anaesthesia was induced with guaifenesin+thiopental and was maintained with isoflurane as required. Lactated Ringer's solution (LRS) was given to all horses during anaesthesia. The outer parts of the resected intestine were harvested, divided in two portions: proximal and distal (a 20 cm segment that we assumed to be viable) to the stenosis, frozen in liquid nitrogen and stored frozen at -80°C.

Four adult horses destined for euthanasia for reasons unrelated to the cardio-vascular system or gastrointestinal tract were used as reference control.

All the studies were approved by the Complutense University Ethical Committee and adhered to the guidelines of Commission Directive 86/609/EEC (The Council Directive of the European Community) concerning the protection of animals used for experimental and other scientific purposes. The National legislation, in agreement with this Directive, is defined in Royal Decree n° 1202/2005.

Isolation of tissue mitochondria

The tissue samples were placed in an ice-cold homogenization buffer (0.32 M sucrose, 1 mM K+EDTA, and 10 mM Tris-Cl, pH 7.4), containing 2.5 mg/ml of fatty acid-free bovine serum albumin (BSA) and 0.3 mM phenylmethylsulfonyl fluoride (PMSF, a protease inhibitor). The sections were minced and homogenized with 2 ml of homogenization buffer per gram of tissue, using a Teflon-glass homogenizer. The homogenate was centrifuged at 500 × g at 4°C for 5 min. The pellet was washed with the homogenization buffer and centrifuged at 500 × g for 5 min (4°C). The supernatant was centrifuged at 10,000 × g at 4°C for 15 min. The mitochondrial pellet was washed once and then resuspended in homogenization buffer. After centrifugation the supernatant was used for cytochrome c determination. The mitochondrial pellet was incubated with lyses buffer and used for NO and CO determination.

Biochemical determinations

For GSH assessment, a specific colorimetric method was used [21]. Briefly, glutathione was sequentially oxidized by 5-5' dithio-bis (2-dinitrobenzoic acid) (DTNB) and reduced by NADPH in the presence of glutathione disulfide reductase, which results in the formation of 5-thio-2-nitrobenzoic acid (TNB). The rate of TNB formation is measured spectrophotometrically at 412 nm.

Cellular content of adenosine tri phosphate (ATP) and lipid hydroperoxides (LPO) were measured by spectrophotmetry using commercially available kits (Sigma, St. Louis, Missouri, USA; Camille Biochemical Company, Thousand Oaks, CA, USA, and).

For ATP determination, a portion of tissue was homogenised in tris-EDTA buffer, pH 7.75, containing 0.3% trichloroacetic acid, and centrifuged (3000 g, for 10 minutes). ATP measurement was based on two consecutive reactions; in the first one, ATP is transformed to adenosyl diphosphate (ADP) and 1,3-diphosphoglycerate in the presence of 3-phosphoglycerate phosphokinase); in the following reaction, catalyzed by glyceraldehyde-phosphate-dehydrogenase, 1,3-diphosphoglycerate in the presence of NADH+H is transformed in glyceraldehyde-3-P and NAD+P. The reduction of absorbance at 340 nm due to the oxidation of NADH to NAD is proportional to the amount of ATP in the sample [22, 23].

Lipid hydroperoxides were extracted from the sample into chloroform before performing the assay. Briefly, tissue was homogenized in buffer phosphate saturated methanol and centrifuged, 3,000 × g, for 10 minutes. Five hundred microliters of the supernatant were aliquot into a glass test tube and an equal volume of cold chloroform was added and mixed thoroughly by vortexing, and centrifuged again at 1,500 × g for 5 minutes at 0°C. Bottom chloroform layer was collected and transferred to another test tube for LPO measurement. The basis of the LPO determination is the reaction of hydroperoxides with 10-N-methylcarbamoil-3,7-dimethylamino-10-10-fenotiacine, catalyzed by haemoglobin, which leads to methylene blue formation. The methylene blue formed was then measured colorimetrically [22, 23].

NO release was measured by the Griess reaction as NO2 concentration after NO3 reduction to NO2. Briefly, samples were deproteinized by the addition of sulfosalicylic acid, were then incubated for 30 min at 4°C, and subsequently centrifuged for 20 minutes at 12,000 g. After incubation of the supernatants with Escherichia coli NO3 reductase (37°, 30 min), 1 ml of Griess reagent (0.5% naphthylenediamine dihydrochloride, 5% sulfonilamide, 25% H3PO4) was added. The reaction was performed at 22°C for 20 min, and the absorbance at 546 nm was measured, using NaNO2 solution as standard. The measured signal is linear from 1 to 150 μM (r = 0.994, P < 0.001, n = 5), and the detection threshold is ~2 μM.

To quantify the amount of CO released, the ratio of carboxy-haemoglobin after haemoglobin addition was measured. Haemoglobin (4 μM) was added to samples and the mixture was allowed to react for 1 min, to be sure of a maximum binding of CO to haemoglobin. Then, samples were diluted with a solution containing phosphate buffer (0.01 mol/L monobasic potassium phosphate/dibasic potassium phosphate, pH 6.85) containing sodium dithionite, and after 10 min at room temperature, absorbance was measured at 420 and 432 nm against a matched curve containing only buffer.

MAT activity was assayed as described by Cantoni [24, 25]) and Duce [25]. Briefly, the incubation mixture consisted of 100 mM Tris-HCl (pH 7.8), 200 mM KCl, 10 mM MgCl2, 1 mM dithiothreitol,, 5 mM ATP and 5 mM L-methionine containing 0.2 μCi/ml methyl-L-[3H]methionine (Radiochemical Center, Amersham, Buckinghamshire, UK). The reaction was initiated by the addition of the sample and 30 min later was stopped with cold distilled water. The incubation mixture was immediately applied to a 2 ml Dowex AG 50 W column. The column was washed with 20 ml distilled water and the [3H]SAMe formed was then eluted with two fractions of 3 ml of 3 N ammonium hydroxide. The s-adenosyl-L-methionine formed was determined by counting in 10 ml F-1 Normascint scintillation liquid (Scharlau). The reaction was linear with time for at least 30 min.

Phospholipid Met Tase was determined as described elsewhere [25]. This method is based on the determination of the incorporation of [3H]methyl groups from S-adenosyl-L-(methyl-3H)methionine (Radiochemical Center, Amersham, Buckinghamshire, UK) into phospholipids. The reaction mixture contained 10 Mm 4,2-hydroxyethyl-1-piperazine ethanesulfonic acid (HEPES) (pH 7.3), 4 mM dithiothreitol, 5 mM MgCl2, 100 μM S-adenosyl methionine, 2 μCi S-adenosyl-L-(methyl-3H)methionine and 50 μl of sample. The reaction was initiated by the addition of a mixture of the labelled and unlabeled S-adenosyl methionine and terminated by pipetting 100 μl assay mixture into 2 ml chloroform/methanol/2 N HCl (6:3:1, v/v/v) for lipid extraction. The chloroform phase was washed with 1 ml 0.5 M KCl in 50% methanol. After washing, 0.6 ml of the chloroform phase was pipetted into a counting vial, dried at room temperature, dissolved into 5 ml Normascint-11 scintillation liquid (Scharlau) and counted.

Results are expressed in relation to the concentration of tissue proteins to correct differences in the amount of cell per surface, secondary to intestinal wall dilation. Protein determination was performed by the Bradford method. The basis of this method is the addition of Coomassie brilliant blue dye/colorant to proteins. This union induces a shift in maximum dye absorbance from 465 to 595 nm. Absorbance is measured at 595 nm, comparing to a known standard curve.

Reproducibility within the assays was evaluated in three independent experiments. Each assay was carried out with three replicates. In all assays, the intra-assay coefficient of variation was <5%, and the inter-assay coefficient of variation was <6%.

Statistical analysis

Results are expressed as the mean ± SEM. Mean comparison was done by the Kuskal-Wallis test followed by a Mann Whitney test; a confidence level of 95% (p < 0.05) was considered significant.

Results

MAT activity was reduced in both, distal and proximal portions of jejunum obtained of colic horses, compared with the MAT activity observed in the intestine of healthy horses (Fig. 1A). Met Tase activity was also lower in the portion of intestine proximal to the stenosis compared to the distal group, however, no differences were observed between distal portion and healthy horses (Fig. 1B).
Figure 1

Methionine adenosyl transferase (MAT) and methyl transferase (MetTase) activities in jejunum of colic horses.

GSH content of tissue distal to the stenosis was significantly lower than that of the healthy horses, and a further reduction was observed in the proximal portion (Fig. 2). By contrary, LPO levels were lower in intestinal tissue of healthy horses compared with colic horses. LPO levels were higher in cells from the proximal portion as compared to those from the distal portion (Fig. 3).
Figure 2

Glutathione (GSH) content of jejunum homogenates.

Figure 3

Lipid peroxides (LPO) content of jejunum homogenates.

As shown in figure 4, ATP content followed a pattern similar to that of GSH. ATP was reduced in the proximal portion to the stenosis compared to the distal one.
Figure 4

Adenosyl triphosphate (ATP) content jejunum homogenates.

The NO and CO content (released by) in mitochondria gave higher values in the proximal portion as compared with the distal group (Fig. 5). No differences were observed between distal portion and healthy horses.
Figure 5

Nitric oxide (NO) and carbon monoxide (CO) level in jejunum homogenates.

Discussion

It is generally accepted that the intestinal mucosa is extremely sensitive to ischemia. Ischemia injury causes misdistribution of blood flow, damage to endothelium, coagulation abnormalities, and aggregation of platelets and neutrophils. The activation of neutrophils leads to the release of reactive oxygen species (ROS) including superoxide anion (O2-) and H2O2.

Free radicals generated by polymorphonuclear leucocytes, macrophages and other cells, may have a role in intestinal dysfunction secondary to ischemia [1, 5, 26]. One of the most immediate actions of free radicals is the peroxidation of membrane lipids which is implicated as the underlying cause of cell injury in many conditions involving oxidative stress. Although the mechanisms of lipid peroxidation have been extensively studied, controversy still remains as to the critical and irreversible steps leading to cell injury and the therapeutic potential of intervention [27]. In this study, we measured LPO levels as damage indices in the intestine. We found a considerable increase in the intestinal tissue levels of LPO in the outer parts of resected intestine segments isolated from colic horses compared with those isolated from healthy horses, and this increase was more marked in the proximal portion to the stenosis compared with the distal portion, indicating that free radicals, secondary to intestinal ischemia, promote the peroxidation of intestinal lipids. Interestingly, higher LPO levels were also found in the distal (macroscopically viable) portion of intestine resected compared with those isolated from healthy horses. We can speculated that the ischemic intestine releases proinflammatory molecules, such as hydrogen peroxide (H2O2), superoxide radicals (O2-), cytokines (e.g., tumour necrosis factor-α), and arachidonic acid metabolites into the portal and systemic circulation, all of which can induce direct tissue damage. However, these molecules are also potent activators of leukocytes and thereby promote their sequestration to the neighborhood, increasing damage to intestine.

Several inflammatory mediators can be released during equine colic [3, 28]. Nitric Oxide (NO) is one molecular mediator involved in both the inflammatory response [29] and oxidative damage [8, 30]. During defence reactions there seems to be a close relationship between both free radicals and NO production. NO reacts with oxygen to yield peroxynitrites, which is a strong oxidant.

In accordance with previous reports, which show that iNOS activity and NO release are increased after ischemia injury in several tissues [3133], in the present study NO release to the mitochondrial fraction was found to be increased in the portion of jejunum proximal to the stenosis compared with the distal group. It is likely that NO is produced in the intestinal tissue during different processes such as vascular regulation and host defence. In addition, it is conceivable that NO produced by any cell may exert paracrine effects in neighboring cells, then amplifying tissue damage.

GSH is probably the most important cellular antioxidant. There is evidence for an evolutionary link between GSH and eukaryotic cell metabolism [34] indicating that GSH evolved as a molecule that protects cells against oxygen toxicity. Intracellular GSH acts both as a nucleophilic "scavenger", converting electrophylic compounds to thioether conjugates, and as a substrate in the GSH peroxidase-mediated destruction of hydroperoxides [35]. GSH can prevent covalent binding of reactive metabolites to critical cellular macromolecules and lipid peroxidation [14], both of which are major mechanisms mediating cell injury and/or death. Glutathione (GSH) deficiency leads to severe degeneration of the epithelial cells of the jejunum and colon [16]. Administration of GSH have a protective effect on the gastrointestinal epithelium and may also serve as a good source of cysteine for intracellular GSH synthesis in the gastrointestinal tract and in other tissues [16]. In this study, a reduction in GSH levels in the portion of jejunum proximal to the stenosis was observed. This fact could be either cause or consequence of the increase in the intestinal ischemia-related oxidative/antioxidative imbalance.

SAMe, an endogenous cellular metabolite that acts as methyl donor in most of biological transmethylation reactions, is also able to act as an antioxidant and free radical scavenger in vitro [36]. It has also shown to exert protective effects on different experimental pathological models, in which free radicals and ROS are involved, such as brain ischemia-reperfusion [37], cytokine-induced toxicity [38], liver cirrhosis [3942], cholestatic liver disease [4346] and in the exposure to hepatotoxic agents [17]. Thus it seemed interesting to look into the implication of this molecule during equine colic, during which, release of free radicals seems to be involved [1, 5].

A decrease in MAT activity in the outer parts of resected jejunum segments isolated from colic horses compared with those isolated from healthy horses has been found in this study, and this decrease was more marked in the proximal portion of stenosis compared with the distal portion. This finding is in accordance with previous studies in humans and experimental animals, in which a decrease in liver-specific MAT activity in several pathological situations was observed [17, 25, 39]. However, to our knowledge this is the first work showing a decrease in MAT activity in the intestine of colic horses with intestinal ischemia. This reduction in MAT activity would lead to a decrease in SAMe synthesis, which would affect many essential metabolic pathways in which SAMe is involved, such as GSH synthesis. Oxidative stress could be involved in this intestinal ischemia-related decrease in MAT activity, since it is known that both ROS [47, 48] and NO [49] are able to inactivate liver MAT. This situation would lead to a self-perpetuating cycle, in which the free radicals generated would induce a GSH depletion, thus increasing oxidative stress that would inactivate MAT, which would further reduce SAMe and GSH synthesis [50, 51].

On the other hand, in our study intestinal ischemia induced an increase in cellular oxidative stress (as shown by the increase in LPO content) and NO release, and these factors could account for the reduction in MAT activity. This decrease in MAT activity has been proposed to be an adaptative mechanism to spare ATP, whose levels are usually compromised under pathological situations, by reducing its consumption in SAMe and GSH synthesis and leaving it available for other basic cellular functions [17]. In this study, a reduction in GSH levels in the portion of jejunum proximal to the stenosis was also found, which could be both cause and consequence of the decrease in MAT activity.

SAMe can also contribute to preserve cell membrane integrity, preventing membrane lipid peroxidation and maintaining phospholipid methylation, and membrane fluidity. In this study, we also found a colic-associated decrease in MetTase activity, a fact that has also been found in other pathological situations [25, 52]. Given that Met Tase plays an important role catalyzing the methylation of phosphatidyl ethanolamine to produce phosphatidyl choline (PC), which is an essential molecule for cell membrane integrity, we can hypothesized that this decrease in Met Tase could contribute to ischemia-induced intestinal tissue injury.

It is known that impairment in mitochondrial function, may lead to an increase in the rate of ROS production in mitochondria and this fact could be a major mechanism for the intestinal ischemia-related increase in oxidative damage in colic horses. Impairment in structure and/or mitochondrial function may lead to a reduction of the energy supply to the cells. These observations are in accordance with our present results, in which a decrease in ATP content of the intestinal tissue resected from colic horses, compared with those obtained from healthy horses. Accumulation of oxidative damage could be involved in this phenomenon, since oxidative stress is able to inhibit mitochondrial respiration [6] leading to organ dysfunction and cell death.

CO is a physiologically synthesized molecule that shares some of the mechanisms of action and physiological effects of NO [9, 53]. The main endogenous source of CO is heme metabolism by heme-oxygenase (HO) [9, 53]. This HO-CO pathway has been recently proposed to be involved in the defence against oxidative stress and the deleterious effects of NO, since it removes the cytotoxic free heme, and produces some molecules with antioxidant and anti-inflammatory effects, such as biliverdin and CO [9, 5456]. Therefore, this pathway could be activated to counteract an excess of oxidant and inflammatory agents [9]. The present study shows that intestinal ischemia induces an increase in local CO production in intestine, and this fact could mean that this defence mechanism has been activated by the increase in colic-associated ROS and proinflammatory molecules, such as NO.

Conclusion

In conclusion, our results suggest that intestinal ischemia in horses can be accompagnied with an oxidative/antioxidative imbalance. This effect could be mediated, at least in part by impairment in glutathione and/or SAMe metabolism, suggesting a possible application for these molecules in the preventive and/or therapeutic approach to intestinal ischemia-induced damage. Further investigation is needed to elucidate their efficacy and establish if they can be used clinically.

Abbreviations

ADP: 

adenosyl diphosphate

ATP: 

adenosine triphosphate

BSA: 

bovine serum albumin

cGMP: 

cyclic-guanosyl monophosphate

CO: 

carbon monoxide

DTNB: 

5-5' dithio-bis (2-dinitrobenzoic acid)

EDTA: 

ethylene diamine tetra acetic

GSH: 

glutathione

HEPES: 

4,2-hydroxyethyl-1-piperazine ethanesulfonic acid

HO-1: 

heme-oxygenase 1

LPO: 

lipid hydroperoxides

MAT: 

methionine-adenosyl-transferase

MetTase: 

methyl-transferases

NAD: 

oxidized form of nicotin adenin dinucleotide

NADH+H: 

reduced form of nicotin adenine dinucleotide

NADPH+H: 

reduced form of nicotin adenine dinucleotide phosphate

NO: 

nitric oxide

P: 

phosphate group

PMSF: 

phenylmethylsulfonyl fluoride

RNS: 

reactive nitrogen species

ROS: 

reactive oxygen species

SAMe: 

S-Adenosyl methionine

sGC: 

soluble-guanilyl cyclase

TNB: 

5-thio-2-nitrobenzoic acid.

Declarations

Acknowledgements

This work was supported by grants from the Ministerio de Educación, Cultura y Deportes of Spain.

The skilful technical assistance of Ana García Quiralte is gratefully acknowledged.

Authors’ Affiliations

(1)
Horsepital SL, Villanueva del Pardillo
(2)
Department of Biochemistry and Molecular Biology, Medical School, University Complutense of Madrid
(3)
Department of Animal Medicine and Surgery, Veterinary School, University Complutense of Madrid

References

  1. Meyers K, Reed S, Keck M, Clem M, Bayly W: Circulating endotoxin-like substance(s) and altered hemostasis in horses with gastrointestinal disorders: an interim report. Am J Vet Res. 1982, 43: 2233-2238.PubMedGoogle Scholar
  2. Welles EG, Prasse KW, Moore JN: Use of newly developed assays for protein C and plasminogen in horses with signs of colic. American Journal Of Veterinary Research. 1991, 52 (2): 345-351.PubMedGoogle Scholar
  3. Davis JL, Papich MG, Morton AJ, Gayle J, Blikslager AT, Campbell NB: Pharmacokinetics of etodolac in the horse following oral and intravenous administration. Journal Of Veterinary Pharmacology And Therapeutics. 2007, 30 (1): 43-48. 10.1111/j.1365-2885.2007.00811.x.View ArticlePubMedGoogle Scholar
  4. Tschetter JR, Blikslager AT, Little D, Howard RD, Woody SL, Beex LM, Crisman MV: Detection of differentially regulated genes in ischaemic equine intestinal mucosa. Equine Veterinary Journal. 2005, 37 (4): 319-324. 10.2746/0425164054529382.View ArticlePubMedGoogle Scholar
  5. Moore R: Clinical relevance of intestinal reperfusion injury in horses. J Am Vet Med Assoc. 1997, 211: 1362-1366.PubMedGoogle Scholar
  6. Sastre JPF, Vina J: Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life. 2000, 49 (5): 427-435. 10.1080/152165400410281.View ArticlePubMedGoogle Scholar
  7. Reiter RJTD, Cabrera J, D'Arpa D, Sainz RM, Mayo JC, Ramos S: The oxidant/antioxidant network: role of melatonin. Biol Signals and Recept. 1999, 8: 56-63. 10.1159/000014569.View ArticleGoogle Scholar
  8. Reiter R: Oxidative damage in the central nervous system: protection by melatonin. Progress in Neurobiology. 1998, 56: 359-384. 10.1016/S0301-0082(98)00052-5.View ArticlePubMedGoogle Scholar
  9. Ryter SWOL, Morse D, Choi AM: Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem. 2002, 234–235: 249-263. 10.1023/A:1015957026924.View ArticlePubMedGoogle Scholar
  10. Kaplovitz NOM: The regulation of hepatic glutathione. Annu Rev Toxicol. 1985, 25: 715-719. 10.1146/annurev.pa.25.040185.003435.View ArticleGoogle Scholar
  11. Dröge W: Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol. 2002, 37: 1333-1345. 10.1016/S0531-5565(02)00175-4.View ArticlePubMedGoogle Scholar
  12. Meister A, Anderson ME: Glutathione. Annu Rev Biochem. 1983, 52: 711-713. 10.1146/annurev.bi.52.070183.003431.View ArticlePubMedGoogle Scholar
  13. Weinberg JMDJA, Abarzua M, Rajan T: Cytoprotective effects of glycine and glutathione against hypoxia injury to renal tubes. J Clin Invest. 1987, 80: 1446-1454. 10.1172/JCI113224.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Barcley LR: The cooperative antioxidant role of glutathione with lipid-solube and water-solube antioxidant during peroxidation of liposomes initiated in the aqueous phase and in the lipid phase. J Biol Chem. 1988, 263: 16138-16142.Google Scholar
  15. Martesson J, Meister A: Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc Natl Acad Sci USA. 1989, 86: 471-475. 10.1073/pnas.86.2.471.View ArticleGoogle Scholar
  16. Martensson J, Jaint A, Meister A: Glutathione is required for intestinal function. Proc Natl Acad Sci USA. 1990, 87: 1715-1719. 10.1073/pnas.87.5.1715.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Mato JMAL, Ortiz P, Pajares MA: S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997, 73: 265-280. 10.1016/S0163-7258(96)00197-0.View ArticlePubMedGoogle Scholar
  18. Ko K, Yang H, Noureddin M, Iglesia-Ara A, Xia M, Wagner C, Luka Z, Mato JM, Lu SC: Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab Invest. 2008, 88: 1121-1129. 10.1038/labinvest.2008.69.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Semmler A, Smulders Y, Struys E, Smith D, Moskau S, Blom H, Linnebank M: Methionine metabolism in an animal model of sepsis. Clin Chem Lab Med. 2008, 46: 1398-1402. 10.1515/CCLM.2008.277.View ArticlePubMedGoogle Scholar
  20. White N: Examination and diagnosis of the acute abdomen. Philadelphia: Lea & Febiger; 1990:102–142:Google Scholar
  21. Owens CW, Belcher RV: A colorimetric micro-method for the determination of glutathione. Biochem J. 1965, 94: 705-711.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Castillo C, Salazar V, Ariznavarreta C, Vara E, Tresguerres JAF: Effect of recombinant human growth hormone on age-related hepatocyte changes in old male and female wistar rats. Endocrine. 2004, 25: 33-39. 10.1385/ENDO:25:1:33.View ArticlePubMedGoogle Scholar
  23. Castillo C, Salazar V, Ariznavarreta C, Vara E, Tresguerres JAF: Effect of growth hormone and estrogen administration on hepatocyte alterations in old ovariectomized female wistar rats. Endocrine. 2005, 26 (1): 11-18. 10.1385/ENDO:26:1:011.View ArticlePubMedGoogle Scholar
  24. Cantoni G: S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind placebo-controlled study. Gastroenterology. 1990, 99: 211-215.Google Scholar
  25. Duce AM, Ortíz P, Cabrero C, Mato JM: S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology. 1988, 8: 65-68. 10.1002/hep.1840080113.View ArticlePubMedGoogle Scholar
  26. Nosalova V, Navarova J, Mihalova D, Sotnikova R: Evaluation of the modulatory role of nimodipine in mesentreric ischaemia/reperfusion-induced intestinal and vascular damage effect of stobadine. Methods Find Exp Clin Pharmacol. 2007, 29 (1): 39-43. 10.1358/mf.2007.29.1.1063495.View ArticleGoogle Scholar
  27. Tribble D, Aw TY, Jones DP: The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology. 1987, 7: 377-386. 10.1002/hep.1840070227.View ArticlePubMedGoogle Scholar
  28. Jackman BR, Moore JN, Barton MH, Morris DD: Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxemia. Can J Vet Res. 1994, 58 (2): 138-143.PubMed CentralPubMedGoogle Scholar
  29. Boveris AAS, Navarro A: The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med. 2002, 339: 1186-1193. 10.1016/S0891-5849(02)01009-2.View ArticleGoogle Scholar
  30. Szabo C: Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003, 140–141: 105-112. 10.1016/S0378-4274(02)00507-6.View ArticlePubMedGoogle Scholar
  31. Chung HY, Kim HJ, Kim KW, Choi JS, Yu BP: Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc Res Tech. 2002, 59: 264-272. 10.1002/jemt.10203.View ArticlePubMedGoogle Scholar
  32. Castillo CSV, Ariznavarreta C, Vara E, Tresguerres JA: Effect of recombinant human growth hormone on age-related hepatocyte changes in old male and female Wistar rats. Endocrine. 2004, 25: 33-39. 10.1385/ENDO:25:1:33.View ArticlePubMedGoogle Scholar
  33. Barocelli E: The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide: Biology And Chemistry. 2006, 14 (3): 212-218. 10.1016/j.niox.2005.11.006.View ArticleGoogle Scholar
  34. Fahey R, Sundquist AR: Evolution of glutathione metabolism. Adv Enzymol. 1991, 64: 1-53.PubMedGoogle Scholar
  35. Ross D: Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free radical induced toxicity and glutathione-dependent protection. Pharmacol Ther. 1988, 37: 16138-16142. 10.1016/0163-7258(88)90027-7.Google Scholar
  36. Evans PJ, Whiteman M, Tredger JM, Halliwell B: Antioxidant properties of S-adenosyl-L-methionine: a proposed addition to organ storage fluids. Free Radic Biol Med. 1997, 23: 1002-1008. 10.1016/S0891-5849(97)00124-X.View ArticlePubMedGoogle Scholar
  37. De La Cruz JPVM, Cuerda MA, Guerrero A, Gonzalez-Correa JA, Sanchez De La Cuesta F: Effects of S-adenosyl-L-methionine on lipid peroxidation and glutathione levels in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation. Neurosci Lett. 2002, 318: 103-107. 10.1016/S0304-3940(01)02475-2.View ArticlePubMedGoogle Scholar
  38. Arias-Diaz JVE, Garcia C, Villa N, Rodriguez JM, Ortiz P, Balibrea JL: S-adenosylmethionine protects hepatocytes against the effects of cytokines. J Surg Res. 1996, 62: 79-84. 10.1006/jsre.1996.0177.View ArticlePubMedGoogle Scholar
  39. Avila MAG-TE, Martinez-Chantar ML, Latasa MU, Perez-Mato I, Martinez-Cruz LA, del Pino MM, Corrales FJ, Mato JM: S-Adenosylmethionine revisited: its essential role in the regulation of liver function. Alcohol. 2002, 27: 163-167. 10.1016/S0741-8329(02)00228-8.View ArticlePubMedGoogle Scholar
  40. Lieber C: Role of S-adenosyl-L-methionine in the treatment of liver diseases. J Hepatol. 1999, 30: 1155-1159. 10.1016/S0168-8278(99)80274-8.View ArticlePubMedGoogle Scholar
  41. Lieber C: S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Alcohol. 2002, 27: 173-177. 10.1016/S0741-8329(02)00230-6.View ArticlePubMedGoogle Scholar
  42. Mato JMCJ, Fernandez de Paz J, Caballeria L, Coll S, Caballero A, Garcia-Buey L, Beltran J, Benita V, Caballeria J, Sola R, Moreno-Otero R, Barrao F, Martin-Duce A, Correa JA, Pares A, Barrao E, Garcia-Magaz I, Puerta JL, Moreno J, Boissard G, Ortiz P, Rodes J: S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 1999, 30: 1081-1089. 10.1016/S0168-8278(99)80263-3.View ArticlePubMedGoogle Scholar
  43. Frezza MCG, Cammareri G, Le Grazie C, Di Padova C: S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology. 1990, 37 (Suppl 2): 122-125.PubMedGoogle Scholar
  44. Frezza MSC, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C: Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology. 1990, 99: 211-215.PubMedGoogle Scholar
  45. Muriel PSO, Gonzalez P, Zuniga L: Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol. 1994, 21: 95-102. 10.1016/S0168-8278(94)80143-6.View ArticlePubMedGoogle Scholar
  46. Belli DC, Fournier LA, Lepage G, Yousef I, Roy CC: S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat. J Hepatol. 1994, 21: 18-23. 10.1016/S0168-8278(94)80131-2.View ArticlePubMedGoogle Scholar
  47. Sanchez-Gongora ERF, Mingorance J, An W, Corrales FJ, Mato JM: Interaction of liver methionine adenosyltransferase with hydroxyl radical. FASEB J. 1997, 11: 1013-1019.PubMedGoogle Scholar
  48. Avila MA, Corrales FJ, Ruiz F, Sanchez-Gongora E, Mingorance J, Carretero MV, Mato JM: Specific interaction of methionine adenosyltransferase with free radicals. Biofactors. 1998, 8: 27-32. 10.1002/biof.5520080106.View ArticlePubMedGoogle Scholar
  49. Ruiz FCF, Miqueo C, Mato JM: Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation. Hepatology. 1998, 28: 1051-1057. 10.1002/hep.510280420.View ArticlePubMedGoogle Scholar
  50. Corrales FOP, Rivas C, Martin-Lomas M, Mato JM, Pajares MA: Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction. Hepatology. 1991, 14: 528-533.PubMedGoogle Scholar
  51. Corrales FÁL, Pajares MA, Ortiz P, Mato JM: Impairment of methionine metabolism in liver disease. Drug Investigation. 1992, 4 (Suppl 4): 8-13.View ArticleGoogle Scholar
  52. Chawla RK, Jones DP: Abnormal metabolism of S-adenosyl-L-methionine in hypoxic rat liver. Similarities to its abnormal metabolism in alcoholic cirrhosis. Biochim Biophys Acta. 1994, 1199: 45-51.View ArticlePubMedGoogle Scholar
  53. Baranano DE, Snyder SH: Neural roles for heme oxygenase: contrast to nitric oxide synthase. PNAS. 2001, 98: 10996-11002. 10.1073/pnas.191351298.PubMed CentralView ArticlePubMedGoogle Scholar
  54. Guo XSV, Cho CH: Modulation of heme oxagenase in tissue injury and its implication in protection against gastrointestinal diseases. Life Sci. 2001, 69: 3113-3119. 10.1016/S0024-3205(01)01417-5.View ArticlePubMedGoogle Scholar
  55. Henningsson RAP, Lundquist I: Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia. Am J Physiol Cell Physiol. 2001, 280: C1242-1254.PubMedGoogle Scholar
  56. Otterbein LE, Bach FHAJ, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine. 2000, 6: 422-428. 10.1038/74680.View ArticlePubMedGoogle Scholar

Copyright

© Marañón et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement